Oaktree Acquisition Corp. III Life Sciences SEC filings OACCU
Oaktree Acquisition Corp. III Life Sciences has 66 filings in SEC EDGAR's recent list, going back to Aug 7, 2024. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (unregistered share sale, bylaw or fiscal year change, shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change, Shareholder vote results
|
Oct 26, 2026 | Oct 23, 2026 |
| DEFA14A | Additional proxy material | Oct 16, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 16, 2026 | Oct 16, 2026 |
| DEFA14A | Additional proxy material | Oct 15, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 15, 2026 | Oct 14, 2026 |
| DEF 14A | Proxy statement | Oct 2, 2026 | Oct 16, 2026 |
| PRE 14A | Preliminary proxy statement | Sep 21, 2026 | Sep 21, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 29, 2025 | Oct 29, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 17, 2025 | Oct 17, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 6, 2025 | Jun 3, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 7, 2025 | Jan 6, 2025 |
| 8-K |
Current report
Other events
|
Dec 11, 2024 | Dec 11, 2024 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Nov 5, 2024 | Oct 30, 2024 |
| 8-K |
Current report
Other events
|
Oct 31, 2024 | Oct 25, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Oct 25, 2024 | Oct 23, 2024 |
| 424B4 | Prospectus | Oct 24, 2024 | — |
| CERT | Filing | Oct 24, 2024 | — |
| EFFECT | Filing | Oct 23, 2024 | — |
| 8-A12B | Filing | Oct 23, 2024 | — |
| CORRESP | Letter to the SEC | Oct 21, 2024 | — |
| CORRESP | Letter to the SEC | Oct 21, 2024 | — |
| CORRESP | Letter to the SEC | Oct 18, 2024 | — |
| S-1/A | Amended registration statement | Oct 18, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 18, 2024 | — |
| CORRESP | Letter to the SEC | Oct 4, 2024 | — |
| S-1 | Registration statement | Oct 4, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 1, 2024 | — |
| DRSLTR | Filing | Sep 13, 2024 | — |
| DRS/A | Filing | Sep 13, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 5, 2024 | — |
| DRS | Filing | Aug 7, 2024 | — |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Blank Checks (SIC 6770)
- Listed as
- OACC (Nasdaq), OACCU (Nasdaq), OACCW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Los Angeles, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2029769
Other Blank Checks companies
- Drugs Made In America Acquisition II Corp. DMII
- EQV Ventures Acquisition Corp. II EVAC
- Bain Capital GSS Investment Corp. BCSS
- Cantor Equity Partners IV, Inc. CEPF
- Churchill Capital Corp XII CXII
- American Exceptionalism Acquisition Corp. A AEXA
- New America Acquisition I Corp. NWAX
- Ares Acquisition Corp III AAC
Source: SEC EDGAR filings. This is company-reported data, not investment advice.